Editas Medicine, Inc.
EDIT
$2.79
-$0.0365-1.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 597.47% | 310.40% | -49.03% | -98.86% | -82.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 597.47% | 310.40% | -49.03% | -98.86% | -82.23% |
| Cost of Revenue | -70.15% | -45.49% | -30.11% | 17.59% | 82.04% |
| Gross Profit | 76.53% | 53.97% | -89.41% | -35.26% | -99.68% |
| SG&A Expenses | -29.37% | -30.84% | 13.14% | 20.69% | 5.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -59.90% | -41.33% | -22.67% | 18.43% | 54.14% |
| Operating Income | 64.59% | 47.29% | -43.40% | -30.91% | -63.07% |
| Income Before Tax | 21.26% | -22.82% | -140.52% | -38.03% | -67.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 21.26% | -22.82% | -140.52% | -38.03% | -67.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.26% | -22.82% | -140.52% | -38.03% | -67.80% |
| EBIT | 64.59% | 47.29% | -43.40% | -30.91% | -63.07% |
| EBITDA | 66.48% | 49.08% | -46.60% | -31.69% | -65.63% |
| EPS Basic | 23.22% | -21.16% | -137.88% | -36.63% | -45.51% |
| Normalized Basic EPS | 60.85% | 43.89% | -89.93% | -36.62% | -45.52% |
| EPS Diluted | 23.22% | -21.16% | -137.88% | -36.63% | -45.51% |
| Normalized Diluted EPS | 60.85% | 43.89% | -89.93% | -36.62% | -45.52% |
| Average Basic Shares Outstanding | 2.55% | 1.36% | 1.11% | 1.03% | 15.32% |
| Average Diluted Shares Outstanding | 2.55% | 1.36% | 1.11% | 1.03% | 15.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |